Identifying secreted protein networks affecting human pancreatic islet function in type 2 diabetes using public omic databases

使用公共组学数据库识别影响 2 型糖尿病患者胰岛功能的分泌蛋白网络

基本信息

  • 批准号:
    10372456
  • 负责人:
  • 金额:
    $ 22.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-13 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

The diabetes epidemic affects ~10% of the US adult population. An elevated blood sugar level is the hallmark of diabetes, and the coordinated secretion of endocrine hormones from critically important pancreatic islets of Langerhans is required for the proper control of whole-body glucose metabolism. Increased metabolic stress due to obesity causes each islet cell type (a, b, d) to adapt by altering their hormone secretion. However, in certain obese individuals, failure of this adaptation, disrupts the islet microenvironment, leading to elevated blood glucose levels and the onset of type 2 diabetes (T2D). The underlying mechanisms of how distinct islet cells affect each other’s functions are not known. Secreted proteins are critical intra- and inter- cell type metabolic regulators that have improved our understanding of mechanisms underlying obesity-induced T2D. Thus, the premise of this project is that secreted proteins-mediated crosstalk in islets is essential for proper functioning and adaptation of a, b, d-cells in lean, obese, and T2D states. Secreted proteins comprise ~11% of the total human transcriptome, and our preliminary data have identified ~850 differentially expressed transcripts that encode for secreted proteins in mouse islets with obesity. Yet, the function for only a handful of them has been well-characterized. Our long-term goal is to identify secreted proteins that improve islet function for the treatment of human T2D. A major roadblock towards achieving this goal is the technical limitations in identifying and costly yet time-consuming functional characterization of secreted proteins in islets using conventional biochemical approaches. In a test analysis of one data set at high stringency, 44 islet-derived secreted protein regulators were identified to affect mouse islet function in obesity. Interestingly, the functional characterization of the top candidate secreted protein led to the discovery of a novel pathway inhibiting insulin secretion from b-cells. Excitingly, validation of the use of our quantitative bioinformatics framework is a leap towards effective data mining in expediting the identification of novel secreted protein regulators of islet function associated with the disease state (s). The objective here is to identify secreted protein regulators that affect islet function in human T2D using network analysis on combined publicly available whole islet transcriptomics datasets. We propose the following aims to achieve the objective: 1) Identify candidate secreted protein regulators; 2) superclusters for functional prediction of candidate secreted proteins in islets associated with human obesity and T2D; and 3) biological validation of the candidate secreted proteins to affect islet function. The successful completion will identify novel regulators of islet function in human obesity and T2D, improving knowledge of mechanisms underlying human T2D risks, and possibly identifying therapeutic targets to improve islet function in T2D. Additionally, insights obtained by integrating multiple data sets accounting for variations in sample preparation and sequencing (platform bias), sequencing depths, and networks/correlation architecture (due to sample handling) will form the basis for elucidating the secreted protein network across distinct islet cell-types.
The diabetes epidemic affects ~10% of the US adult population. An elevated blood sugar level is the hallmark of diabetes, and the coordinated secretion of endocrine hormones from critically important pancreatic islets of Langerhans is required for the proper control of whole-body glucose metabolism. Increased metabolic stress due to obesity causes each islet cell type (a, b, d) to adapt by altering their hormone secretion. However, in certain obese individuals, failure of this adaptation, disrupts the islet microenvironment, leading to elevated blood glucose levels and the onset of type 2 diabetes (T2D). The underlying mechanisms of how distinct islet cells affect each other’s functions are not known. Secreted proteins are critical intra- and inter- cell type metabolic regulators that have improved our understanding of mechanisms underlying obesity-induced T2D. Thus, the premise of this project is that secreted proteins-mediated crosstalk in islets is essential for proper functioning and adaptation of a, b, d-cells in lean, obese, and T2D states. Secreted proteins comprise ~11% of the total human transcriptome, and our preliminary data have identified ~850 differentially expressed transcripts that encode for secreted proteins in mouse islets with obesity. Yet, the function for only a handful of them has been well-characterized. Our long-term goal is to identify secreted proteins that improve islet function for the treatment of human T2D. A major roadblock towards achieving this goal is the technical limitations in identifying and costly yet time-consuming functional characterization of secreted proteins in islets using conventional biochemical approaches. In a test analysis of one data set at high stringency, 44 islet-derived secreted protein regulators were identified to affect mouse islet function in obesity. Interestingly, the functional characterization of the top candidate secreted protein led to the discovery of a novel pathway inhibiting insulin secretion from b-cells. Excitingly, validation of the use of our quantitative bioinformatics framework is a leap towards effective data mining in expediting the identification of novel secreted protein regulators of islet function associated with the disease state (s). The objective here is to identify secreted protein regulators that affect islet function in human T2D using network analysis on combined publicly available whole islet transcriptomics datasets. We propose the following aims to achieve the objective: 1) Identify candidate secreted protein regulators; 2) superclusters for functional prediction of candidate secreted proteins in islets associated with human obesity and T2D; and 3) biological validation of the candidate secreted proteins to affect islet function. The successful completion will identify novel regulators of islet function in human obesity and T2D, improving knowledge of mechanisms underlying human T2D risks, and possibly identifying therapeutic targets to improve islet function in T2D. Additionally, insights obtained by integrating multiple data sets accounting for variations in sample preparation and sequencing (platform bias), sequencing depths, and networks/correlation architecture (due to sample handling) will form the basis for elucidating the secreted protein network across distinct islet cell-types.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sushant Bhatnagar其他文献

Sushant Bhatnagar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sushant Bhatnagar', 18)}}的其他基金

Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
  • 批准号:
    10666206
  • 财政年份:
    2023
  • 资助金额:
    $ 22.28万
  • 项目类别:
Identifying secreted protein networks affecting human pancreatic islet function in type 2 diabetes using public omic databases
使用公共组学数据库识别影响 2 型糖尿病患者胰岛功能的分泌蛋白网络
  • 批准号:
    10488268
  • 财政年份:
    2021
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10348695
  • 财政年份:
    2019
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10549803
  • 财政年份:
    2019
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    9913532
  • 财政年份:
    2019
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10090593
  • 财政年份:
    2019
  • 资助金额:
    $ 22.28万
  • 项目类别:
THE ROLE OF TOMOSYN-2 IN INSULIN SECRETION
TomoSYN-2 在胰岛素分泌中的作用
  • 批准号:
    9411112
  • 财政年份:
    2016
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of tomosyn-2 in insulin secretion
Tomosyn-2在胰岛素分泌中的作用
  • 批准号:
    8916088
  • 财政年份:
    2014
  • 资助金额:
    $ 22.28万
  • 项目类别:
The role of tomosyn-2 in insulin secretion
Tomosyn-2在胰岛素分泌中的作用
  • 批准号:
    8766798
  • 财政年份:
    2014
  • 资助金额:
    $ 22.28万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了